FDA approves new treatment for adults with relapsed follicular lymphoma

["U.S. Food and Drug Administration" <fda@xxxxxxxxxx>]

If your email program has trouble displaying this email, view it as a web page

	FDA approves new treatment for adults with relapsed follicular lymphoma
	The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systematic therapies.  Continue reading

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences | Global Unsubscribe